The global cancer vaccines market, valued at US$10.23 billion in 2023, is forecasted to grow at a robust CAGR of 8.6%, ...

Anixa Biosciences CEO Amit Kumar discusses the biotech’s plans for advancing a breast cancer vaccine in 2025. The cancer ...

Russia claims a breakthrough in cancer treatment with a personalized mRNA vaccine, designed to train the immune system to ...

A growing array of pharmaceutical options has investigators trying to figure out which drugs and drug combinations are the ...

Researchers shed light on the genes that could be linked to the high mortality rates of prostate cancer among men of African ...

Russia has reportedly developed a vaccine against cancer that it will launch early next year. The jab, which will be free of ...

Preclinical studies have demonstrated that vaccines targeting prostate and prostate cancer-associated antigens can induce immune responses to those antigens and result in protection from ...

First Commercial mRNA Vaccine Approval Expected By 2029 Says Kuick Research. Delhi, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Global ...

Given the high cancer burden in Nigeria, the Nigerian Cancer Society,NCS, has appealed to the federal government to raise the ...

Cancer vaccines are popularly used to treat various types of cancers such as breast cancer, lung cancer, prostate cancer, and cervical cancer. In addition, it offers numerous benefits as it can stop ...

Madison Vaccines is developing Immune-based Therapies for the treatment of prostate cancer. The company is headquartered in Madison, Wisconsin, the US. For a complete picture of MVI-816’s ...